Quantum Exponential - Board Changes
Announcement provided by
Quantum Exponential Group plc · QBIT28/03/2024 07:00
28 March 2024
Quantum Exponential Group plc
(the 'Company' or 'Quantum Exponential')
Board Changes
Quantum Exponential Group plc (AQUIS: QBIT), a company focused on investing in quantum technology, announces that Stuart Woods will cease to be a director of the Company with effect from 31 March 2024.
Steve Metcalfe, CEO commented:
"I would personally just like to thank Stuart for his strategic insight and guidance during his time with us and wish him all the very best in his future endeavours."
This announcement contains information that, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
The Directors take responsibility for this announcement.
**ENDS**
For more information, visit the Company's website: www.quantumexp.co.uk or contact:
Steven Metcalfe, Chief Executive Officer
Novum Securities (AQSE Corporate Adviser) Tel: +44 (0)20 7399 9400
David Coffman, George Duxberry
VSA Capital (AQSE Corporate Broker) Tel: +44 (0)203 005 5000
Peter Mattsson, Simon Barton
About Quantum Exponential Group plc
Quantum Exponential is a first of its kind, AQSE Growth Market Enterprise Company, focused on opportunities in quantum technology and the wider quantum computing sector, with an advisory board made up of industry advisors, entrepreneurs, and technology investment professionals with broad access to quantum opportunities and markets. Quantum Exponential's investment strategy is to assemble a portfolio of minority investments in early-stage global quantum technology companies, primarily in NATO allied countries, offering institutional and private investors access to revolutionising technologies and industries in the realms of artificial intelligence, manufacturing and healthcare.
Quantum Exponential trades on Aquis Growth Market under the ticker symbol "QBIT".
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.